4: Statement of changes in beneficial ownership of securities-Director Burt Carol
Apr 30 19:02 ET
4: Statement of changes in beneficial ownership of securities-Director Drexler Karen
Apr 30 14:21 ET
144: Notice of proposed sale of securities pursuant to Rule 144
Apr 29 14:59 ET
10-Q: Quarterly report
Apr 26 15:59 ET
8-K: ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Apr 25 16:14 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Mar 6 20:50 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Mar 4 19:16 ET
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:58 ET
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 1 17:12 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Director FARRELL PETER C
Feb 23 18:45 ET
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 22 21:43 ET
ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(12.56%)
Feb 13 22:37 ET
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 6 11:27 ET
ResMed | 10-Q: Quarterly report
Jan 25 15:36 ET
ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.7%)
Jan 25 13:50 ET
ResMed | 8-K: ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
Jan 24 16:12 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Robert Andrew
Jan 3 00:00 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sandercock Brett
Nov 29, 2023 19:45 ET
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 27, 2023 17:26 ET
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Nov 27, 2023 16:33 ET
No Data
No Data